What is Ruxolitinib?

Category: Prescription Drugs

Most popular types: Jakafi

false

Ruxolitinib is a treatment used for blood and bone marrow conditions.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Numbness in hands 2 2
Duane syndrome 1 2
Myelofibrosis 1 2
Myeloproliferative disorder 1 1
Numbness in feet 1 0

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
1
Mild
0
None
2

Commonly reported side effects and conditions associated with Ruxolitinib

Side effect Patients
Headaches 1
Tension headache 1

Dosages

Based on patients currently taking Ruxolitinib

Dosage Patients
25 mg twice daily 2
15 mg twice daily 1

Duration

Currently taking Ruxolitinib

Duration Patients
1 - 2 years 1
2 - 5 years 1
5 - 10 years 1
Adherence
Adherence Evaluations
Always 3
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 3
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 1

What people switch to and from

Patients started taking Ruxolitinib after stopping:

Treatment Patients
Gabapentin (Neurontin) 1
Hydroxyurea (Hydrea) 1
Last updated:
There are no evaluations for Ruxolitinib.